ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/06/21 | 1,600 | 1,650 | 1,600 | 1,640 | +32 | +2% | 47,500 |
2018/06/20 | 1,660 | 1,660 | 1,566 | 1,608 | -53 | -3.2% | 148,200 |
2018/06/19 | 1,705 | 1,723 | 1,647 | 1,661 | -65 | -3.8% | 72,900 |
2018/06/18 | 1,775 | 1,790 | 1,723 | 1,726 | -26 | -1.5% | 84,900 |
2018/06/15 | 1,738 | 1,771 | 1,732 | 1,752 | +19 | +1.1% | 82,500 |
2018/06/14 | 1,740 | 1,758 | 1,715 | 1,733 | -31 | -1.8% | 73,100 |
2018/06/13 | 1,775 | 1,775 | 1,719 | 1,764 | +2 | +0.1% | 70,100 |
2018/06/12 | 1,705 | 1,772 | 1,700 | 1,762 | +62 | +3.6% | 139,100 |
2018/06/11 | 1,670 | 1,710 | 1,652 | 1,700 | +30 | +1.8% | 88,200 |
2018/06/08 | 1,639 | 1,678 | 1,619 | 1,670 | +66 | +4.1% | 103,700 |
2018/06/07 | 1,597 | 1,621 | 1,582 | 1,604 | +16 | +1% | 79,000 |
2018/06/06 | 1,600 | 1,618 | 1,561 | 1,588 | -19 | -1.2% | 102,300 |
2018/06/05 | 1,662 | 1,664 | 1,597 | 1,607 | -58 | -3.5% | 80,600 |
2018/06/04 | 1,660 | 1,674 | 1,639 | 1,665 | +11 | +0.7% | 67,500 |
2018/06/01 | 1,654 | 1,678 | 1,634 | 1,654 | -1 | -0.1% | 69,200 |
2018/05/31 | 1,680 | 1,687 | 1,607 | 1,655 | +15 | +0.9% | 101,300 |
2018/05/30 | 1,562 | 1,642 | 1,545 | 1,640 | +73 | +4.7% | 96,900 |
2018/05/29 | 1,591 | 1,600 | 1,563 | 1,567 | -34 | -2.1% | 68,400 |
2018/05/28 | 1,625 | 1,642 | 1,593 | 1,601 | -25 | -1.5% | 66,900 |
2018/05/25 | 1,650 | 1,719 | 1,617 | 1,626 | -7 | -0.4% | 169,900 |
2018/05/24 | 1,652 | 1,675 | 1,616 | 1,633 | -17 | -1% | 90,400 |
2018/05/23 | 1,687 | 1,687 | 1,642 | 1,650 | -23 | -1.4% | 77,300 |
2018/05/22 | 1,685 | 1,696 | 1,657 | 1,673 | -3 | -0.2% | 53,500 |
2018/05/21 | 1,680 | 1,693 | 1,668 | 1,676 | -9 | -0.5% | 47,900 |
2018/05/18 | 1,689 | 1,708 | 1,652 | 1,685 | -3 | -0.2% | 89,400 |
2018/05/17 | 1,737 | 1,769 | 1,666 | 1,688 | -2 | -0.1% | 141,400 |
2018/05/16 | 1,667 | 1,694 | 1,660 | 1,690 | +23 | +1.4% | 38,900 |
2018/05/15 | 1,653 | 1,669 | 1,644 | 1,667 | +12 | +0.7% | 31,500 |
2018/05/14 | 1,681 | 1,684 | 1,642 | 1,655 | -16 | -1% | 52,600 |
2018/05/11 | 1,670 | 1,706 | 1,631 | 1,671 | -6 | -0.4% | 82,300 |
2018/05/10 | 1,712 | 1,730 | 1,670 | 1,677 | -59 | -3.4% | 101,600 |
2018/05/09 | 1,795 | 1,795 | 1,699 | 1,736 | -80 | -4.4% | 165,300 |
2018/05/08 | 1,775 | 1,826 | 1,755 | 1,816 | +36 | +2% | 113,700 |
2018/05/07 | 1,747 | 1,808 | 1,733 | 1,780 | +69 | +4% | 203,200 |
2018/05/02 | 1,680 | 1,718 | 1,663 | 1,711 | +44 | +2.6% | 109,000 |
2018/05/01 | 1,676 | 1,684 | 1,645 | 1,667 | -7 | -0.4% | 75,800 |
2018/04/27 | 1,628 | 1,678 | 1,616 | 1,674 | +54 | +3.3% | 172,000 |
2018/04/26 | 1,596 | 1,620 | 1,581 | 1,620 | +36 | +2.3% | 73,200 |
2018/04/25 | 1,591 | 1,629 | 1,581 | 1,584 | ±0 | ±0% | 99,500 |
2018/04/24 | 1,564 | 1,594 | 1,564 | 1,584 | +9 | +0.6% | 61,700 |
2018/04/23 | 1,576 | 1,581 | 1,542 | 1,575 | -21 | -1.3% | 121,600 |
2018/04/20 | 1,606 | 1,622 | 1,581 | 1,596 | -18 | -1.1% | 95,800 |
2018/04/19 | 1,648 | 1,654 | 1,602 | 1,614 | -34 | -2.1% | 107,300 |
2018/04/18 | 1,649 | 1,693 | 1,628 | 1,648 | +3 | +0.2% | 91,000 |
2018/04/17 | 1,633 | 1,656 | 1,588 | 1,645 | -28 | -1.7% | 268,000 |
2018/04/16 | 1,700 | 1,700 | 1,606 | 1,673 | +3 | +0.2% | 136,000 |
2018/04/13 | 1,708 | 1,715 | 1,653 | 1,670 | -49 | -2.9% | 162,600 |
2018/04/12 | 1,754 | 1,760 | 1,719 | 1,719 | -35 | -2% | 64,300 |
2018/04/11 | 1,777 | 1,780 | 1,727 | 1,754 | -28 | -1.6% | 88,300 |
2018/04/10 | 1,801 | 1,820 | 1,782 | 1,782 | -41 | -2.2% | 92,100 |
1751~
1800
件表示中 / 2491件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
JCRファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
クオリプス | 739,000円 | +237.1% | - | 0.00% | - | 11.01倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
タウンズ | 58,300円 | +11.5% | -0.9% | 4.80% | 6.98倍 | 3.45倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム